|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of AbbVie (NYSE: ABBV) through any online brokerage.
The latest price target for AbbVie (NYSE: ABBV) was reported by Societe Generale on November 23, 2021. The analyst firm set a price target for 172.00 expecting ABBV to rise to within 12 months (a possible 47.60% upside). 13 analyst firms have reported ratings in the last year.
The stock price for AbbVie (NYSE: ABBV) is $116.53 last updated Fri Nov 26 2021 18:00:00 GMT+0000 (Coordinated Universal Time).
The next AbbVie (ABBV) dividend date is projected to be 2022-01-13.
AbbVie’s $Q4 earnings are confirmed for after-market on February 2, 2022.
There is no upcoming split for AbbVie.
AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.